Preview

Obstetrics, Gynecology and Reproduction

Advanced search

BACTERIAL VAGINOSIS: STATE OF EXPLORATION OF THE PROBLEM

Full Text:

Abstract

In the literature review presents the status of the study of the problem of bacterial vaginosis during and outside of pregnancy, provides criteria of diagnostics and differential diagnostics, standards of treatment and prevention opportunities.

About the Authors

I. O. Makarov
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation


M. A. Gomberg
Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Russian Federation


E. L. Borovkova
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation


L. A. Arakelyan
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation


E. S. Berezovskaya
State Federal-Funded Educational Institution of Higher Vocational Training I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation


References

1. Березовская Е.С., Макаров И.О., Гомберг М.А., Боровкова Е.И., Чулкова Е.А., Аракелян Л.А. Биопленки при бактериальном вагинозе. Акушерство, гинекология и репродукция. 2013; 2: 34-36.

2. Макаров И.О., Боровкова Е.И. Сравнительная эффективность местной терапии бактериального вагиноза у беременных с ожирением. Акушерство, гинекология и репродукция. 2012; 3: 14-17.

3. Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983; 74:14.

4. Andrews W.W., Hauth J.C., Cliver S.P. et al. Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women. Am. J. Obstet. Gynecol. 2006; 195: 1611.

5. Anukam K., Osazuwa E., Ahonkhai I. et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006; 8: 1450.

6. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 108: 776.

7. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet. Gynecol. 2009; 113: 1180.

8. Bohbot J.M., Vicaut E., Fagnen D., Brauman M. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomized phase III study comparing secnidazole and metronidazole. Infect. Dis. Obstet. Gynecol. 2010; 2010.

9. Brocklehurst P., Gordon A., Heatley E., Milan S.J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; 1: CD000262.

10. Bradshaw C.S., Morton A.N., Garland S.M. et al. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J. Clin. Microbiol. 2005; 43: 1304.

11. Briselden A.M., Hillier S.L. Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 1994; 32: 148.

12. Calder n E., Rivera R., Gordillo S., Conde-Glez C. Evaluation of a fast test to identify the presence of proline aminopeptidase in women with bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 1997; 5: 226.

13. Centers for Disease Control and Prevention / Workowski K.A., Berman S.M. Sexually transmitted diseases treatment guidelines. MMWR Recomm. Rep. 2006; 55 (RR-11): 1-94.

14. Fethers K.A., Fairley C.K., Morton A. et al. Early sexual experiences and risk factors for bacterial vaginosis. J. Infect. Dis. 2009; 200: 1662.

15. Falagas M., Betsi G.I., Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin. Microbiol. Infect. 2007; 13: 657.

16. Gillet E., Meys J.F., Verstraelen H. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS One. 2012; 7: e45201.

17. Hill G.B. The microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 1993; 169: 450.

18. Huppert J.S., Hesse E.A., Bernard M.C. et al. Accuracy and trust of self-testing for bacterial vaginosis. J. Adolesc. Health. 2012; 51:400.

19. Koumans E.H., Markowitz L.E., Hogan V. CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 2002; 35: 152.

20. Leitich H. Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best. Pract. Res. Clin. Obstet. Gynaecol. 2007; 21: 375.

21. Lamont R.F., Nhan-Chang C.L., Sobel J.D. et al. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2011; 205: 177.

22. Nygren P., Fu R., Freeman M. et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2008; 148: 220.

23. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991; 29: 297.

24. Oduyebo O.O., Anorlu R.I., Ogunsola F.T. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst. Rev. 2009; CD006055.

25. Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am. J. Obstet. Gynecol. 2008; 198: 97.e1.

26. Schwebke J.R. Asymptomatic bacterial vaginosis: response to therapy. Am. J. Obstet Gynecol. 2000; 183: 1434.

27. Tinidazole (Tindamax) – a new option for treatment of bacterial vaginosis. Med. Lett. Drugs. Ther. 2007; 49: 73.

28. Workowski K.A., Berman S., Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Recomm. Rep. 2010; 59: 1.


For citation:


Makarov I.O., Gomberg M.A., Borovkova E.L., Arakelyan L.A., Berezovskaya E.S. BACTERIAL VAGINOSIS: STATE OF EXPLORATION OF THE PROBLEM. Obstetrics, Gynecology and Reproduction. 2013;7(4):20-24. (In Russ.)

Views: 98


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)